Drug Trial Radar · NCT02565186
An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine
Last checked: Nov 20, 2026Latest source record: Aug 25, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
2,171
Actual
Start
Oct 7, 2015
Primary completion
Aug 20, 2019
Study completion Aug 20, 2019
Sponsor
- Lead sponsor
- Eli Lilly and CompanyEli Lilly (LLY)
- Sponsor type
- Industry
- Collaborators
- CoLucid Pharmaceuticals
- First posted
- Oct 1, 2015
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a prospective, randomized, open-label study in subjects with migraine who have completed the Phase 3 studies, COL MIG 301/LAHJ (NCT02439320) or COL MIG-302/LAHK (NCT02605174) or for a subset of lasmiditan-naïve subjects with migraine. The study is designed to evaluate the safety and tolerability of long-term intermittent use of lasmiditan 100 mg and of lasmiditan 200 mg, as the first dose and as a second dose, for the acute treatment of migraine. Long term efficacy will also be evaluated.
Conditions
- Migraine Disorders
Interventions
LasmiditanDrug
oral tablet
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With at Least 1 Treatment Emergent Adverse EventTime frame: Up to 12 months
Locations
196 sites in 3 countries. Site status is shown where the registry gives one.
Southview Medical Group
Birmingham, Alabama
Simon Williamson Clinic
Birmingham, Alabama
Achieve Clinical Research, LLC
Birmingham, Alabama
Alabama Clinical Therapeutics
Birmingham, Alabama
Medical Affiliated Research Center
Huntsville, Alabama
East Valley Family Physicians, PLC
Chandler, Arizona
Radiant Research
Chandler, Arizona
Warner Family Practice
Chandler, Arizona
Fountain Hills Family Practice, P.C.
Fountain Hills, Arizona
Neurological Physicians of Arizona Inc
Gilbert, Arizona
Thunderbird Internal Medicine
Glendale, Arizona
Thomas C. Lenzmeier, M.D., P.C
Glendale, Arizona
Central Arizona Medical Associates, PC
Mesa, Arizona
Desert Clinical Research
Mesa, Arizona
21st Century Neurology
Phoenix, Arizona
Family Practice Specialists Ltd
Phoenix, Arizona
Central Phoenix Med Clinic LLC
Phoenix, Arizona
Thunderbird Internal Medicine
Phoenix, Arizona
Tatum Highlands Medical Associates, PLLC
Phoenix, Arizona
Radiant Research
Scottsdale, Arizona
Arizona Community Physicians
Tucson, Arizona
Orange Grove Family Practice
Tucson, Arizona
Anaheim Clinical Trials, LLC
Anaheim, California
Radiant Research
Carlsbad, California
The Research Center of Southern California
Carlsbad, California
eStudySite
Chula Vista, California
Allied Clinical Research
Gold River, California
Pharmacology Research Institute
Los Alamitos, California
Pharmacology Research Institute
Newport Beach, California
Pacific Research Partners, LLC
Oakland, California
Desert Valley Research
Rancho Mirage, California
Northern California Clinical Research Center
Redding, California
Anderson Clinical Research
Redlands, California
California Research Foundation
San Diego, California
Artemis Institute for Clinical Research
San Diego, California
Neurological Research Institute
Santa Monica, California
Radiant Research
Santa Rosa, California
Schuster Medical Research Institute
Sherman Oaks, California
Encompass Clinical Research
Spring Valley, California
Radiant Research - Vista CA
Vista, California
Showing 40 of 196 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.